Home » Business, Health & Medicine, Pharmaceuticals & Biotech, Science » Contraceptives Market Was Valued at USD 19.7 Bn in 2015 And is Expected to Reach USD 25.5 Bn By 2022: Credence Research
CredenceResearch.com has Published New Research Report Title “Global Contraceptives Market By Drug Type (Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Devices (Male Condoms, Female Condoms, Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermnal Implants, Intrauterine Devices) – Growth, Share, Opportunities, Competitive Analysis and Forecast 2016 – 2022”

According to the latest report published by Credence Research, Inc. “Contraceptives Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  global contraceptives market was valued at USD 19.7 Bn in 2015, and is expected to reach USD 25.5 Bn by 2022, expanding at a CAGR of 3.6% from 2016 to 2022.

Market Insights:

Contraception is defined as voluntary method of preventing pregnancy by altering fertilization, ovulation and intervention through drugs and devices. This report studies the current status and future prospects of the drugs and devices commercially available in the global contraceptives market. Temporary contraceptives are the most preferred contraception mode across the world. Some of the prime factors that drive the global contraceptives market are drive to avoid unintentional pregnancies and overcoming the risk of sexually transmitted infections. Growing awareness about productive health, and increased approvals for novel and highly effective female contraceptive solutions also drive the contraceptives market. Initiatives by governments and NGOs to promote the use of contraceptives and public concessions for the same are facilitating to growing demand for contraceptives.

Oral contraceptive pills is the largest product segment in the contraceptives market. Combined hormonal contraceptives are in high demand in the present market scenario, due to their high effectiveness and ease of use. Among the device types, intrauterine devices hold the largest market share demonstrating significant usage in developed markets and growing adoption in emerging markets of Asia-Pacific. Subdermal implants and female condoms have developed their niche in the developed regions of North America and Europe and their awareness is steadily increasing in Latin America and Asian markets.

Browse the full report Contraceptives: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/contraceptives-market

North America is the largest market for contraceptives followed by Europe. High incidence of teenage and unintentional pregnancy and wide prevalence of sexually transmitted diseases are the major contributors to the dominance of these regions. On the other hand, novel contraceptive solutions such as implants, vaginal rings and others are in high demand in developed countries due to high disposable incomes and high awareness. Asia-Pacific is the most promising regional market for contraceptive drugs and devices. Government and NGO initiatives focusing on population control, prevention of unintentional pregnancies and sexually transmitted diseases in low income groups are responsible for the surge in demand for contraceptives in Asia-Pacific.

Latest Report:

Drug of Abuse Testing / Screening Market – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. 

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.


Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

Blog: http://www.mobilecomputingtoday.co.uk/3868/global-contraceptives-market-reach-worth-usd-25-5-2022-prevention-unintentional-pregnancies-sexually-transmitted-infections-drive-market-growth-credence-research/

Media Contact
Company Name: Credence Research
Contact Person: Chris Smith, Global Sales Manager
Email: sales@credenceresearch.com
Phone: 1-800-361-8290
Address:105 N 1st ST #429
State: California
Country: United States
Website: http://www.credenceresearch.com/report/contraceptives-market

Comments are closed.